Molecular pathways in non-alcoholic fatty liver disease
Alba Berlanga,1,* Esther Guiu-Jurado,1,* José Antonio Porras,1,2 Teresa Auguet1,21Group GEMMAIR (AGAUR) and Applied Medicine Research Group, Department of Medicine and Surgery, Universitat Rovira i Virgili (URV), IISPV, Hospital Universitari Joan XXIII, Tarragona, Spain; 2Department of In...
Main Authors: | Berlanga A, Guiu-Jurado E, Porras JA, Auguet T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Clinical and Experimental Gastroenterology |
Online Access: | http://www.dovepress.com/molecular-pathways-in-non-alcoholic-fatty-liver-disease-a17486 |
Similar Items
-
Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
by: Teresa Auguet, et al.
Published: (2014-12-01) -
Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
by: Teresa Auguet, et al.
Published: (2017-01-01) -
Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
by: Gemma Aragonès, et al.
Published: (2016-01-01) -
Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
by: Xiaolei Fang, et al.
Published: (2023-07-01) -
The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
by: Mikkel Parsberg Werge, et al.
Published: (2021-03-01)